The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)‐PIM list – a nationwide cross‐sectional study on reimbursement claims data
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.12494
Abstract: The prevalence and risk factors for prescribing and using potentially inappropriate medications (PIMs) has been extensively researched in Western Europe and the United States of America; however, research in Central and Eastern Europe remains highly… read more here.
Keywords: among lithuanian; use potentially; study; inappropriate medications ... See more keywords
Adherence and challenges in administering eye medications among glaucoma patients in a Malaysian public tertiary care centre
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Pharmaceutical Health Services Research"
DOI: 10.1111/jphs.12254
Abstract: To assess the adherence to and identify the challenges in administering eye medications among patients with glaucoma in Malaysia. read more here.
Keywords: challenges administering; eye medications; medications among; administering eye ... See more keywords
Adherence to Antidiabetic Medications among Women with Gestational Diabetes
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Diabetes Research"
DOI: 10.1155/2021/9941538
Abstract: Background Optimal adherence to prescribed medications in women with gestational diabetes is relevant for perinatal outcomes. Objective To summarize available information on the prevalence and factors contributing to medication adherence in women with gestational diabetes… read more here.
Keywords: gestational diabetes; antidiabetic medications; adherence antidiabetic; women gestational ... See more keywords
Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20529
Abstract: e20529Background: Exclusion from cancer clinical trials is common for patients taking QTc-interval prolonging drugs. To estimate the potential impact on accrual, we determined the prevalence of QTc... read more here.
Keywords: prolonging medications; clinical trials; cancer; qtc prolonging ... See more keywords